A randomized phase III study comparing gemcitabine plus pemetrexed versus gemcitabine in patients with locally advanced and metastatic pancreas cancer.

被引：0

作者：

Richards, DA

Kindler, HL

Oettle, H

Ramanathan, RK

Van Laethem, JL

Peeters, M

Fuchs, M

John, W

Arning, M

Von Hoff, D

机构：

[1] US Oncol, Tyler, TX USA

[2] Univ Chicago, Chicago, IL 60637 USA

[3] Univ Clin Charite, Berlin, Germany

[4] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA

[5] Free Univ Brussels, Hop Erasme, B-1070 Brussels, Belgium

[6] State Univ Ghent Hosp, B-9000 Ghent, Belgium

[7] Hosp Munchen Bogenhausen, Munich, Germany

[8] Eli Lilly & Co, Indianapolis, IN 46285 USA

[9] US Oncol, Tucson, AZ USA

[10] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4007

引用

页码：315S / 315S

页数：1